Functional imaging of cognitive impairment in Parkinson's disease (Q37781045)

23 August 2017

title

Functional imaging of cognitive impairment in Parkinson's disease (English)

1 reference

23 August 2017

1 reference

cognitive dysfunction

1 reference

D Eidelberg

1 reference

23 August 2017

T Fitzpatrick

1 reference

23 August 2017

P Mattis

series ordinal

1 reference

23 August 2017

publication date

1 July 2010

1 reference

Clinical EEG and Neuroscience

23 August 2017

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

119-126

1 reference

Clinical diagnostic criteria for dementia associated with Parkinson's disease

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

The Clinical Impression of Severity Index for Parkinson's Disease: international validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

A systematic review of prevalence studies of dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Cognitive impairments in advanced PD without dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Changes in network activity with the progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Executive processes in Parkinson's disease: FDG-PET and network analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Metabolic brain networks associated with cognitive function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Cognitive dysfunction and dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Dopaminergic suppression of brain deactivation responses during sequence learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Can alzheimer's disease and dementias with Lewy bodies be distinguished clinically?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Parkinson disease with dementia: comparing patients with and without Alzheimer pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Functional imaging of working memory in Parkinson's disease: compensations and deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Enhancement of brain activation during trial-and-error sequence learning in early PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Cerebral glucose metabolism in Parkinson's disease with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Metabolic brain networks in neurodegenerative disorders: a functional imaging approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Neuroimaging and therapeutics in movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Network modulation in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Searching for a baseline: functional imaging and the resting human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Parkinson's disease: in vivo assessment of disease progression using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Functional imaging of sequence learning in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Nicotine and nicotinic receptors; relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Differences in neuropathologic characteristics across the Lewy body dementia spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

[11C]PIB binding in Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Imaging amyloid deposition in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Medication impairs probabilistic classification learning in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Effects of levodopa on motor sequence learning in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Learning networks in health and Parkinson's disease: reproducibility and treatment effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Neural correlates of STN DBS-induced cognitive variability in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Changes in cerebral glucose metabolism in patients with Parkinson disease with dementia after cholinesterase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Imaging treatment effects in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Metabolic correlates of levodopa response in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005941004100303

10.1177/155005941004100303

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference